Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ABUS | PRESS-RELEASE | bullish | 7/10 | Arbutus Biopharma reported Q2 2026 revenue of $1.0M (down from $10.7M YoY due to the prior year's Qilu partnership reven | Aug 12, 2026 |
| XLO | PRESS-RELEASE | bullish | 7/10 | Xilio Therapeutics reported Q2 2026 collaboration revenue of $18.7M (up 131% YoY) and a net loss of $6.4M (improved from | Aug 12, 2026 |
| NEXN | PRESS-RELEASE | bullish | 7/10 | Nexxen reported Q2 2026 results that beat consensus EPS ($0.23 vs $0.21) and delivered record Contribution ex-TAC ($97.8 | Aug 12, 2026 |
| AVLN | PRESS-RELEASE | neutral | 5/10 | Avalyn Pharma reported a Q2 2026 net loss of $28.9M ($-0.56 EPS, in line with consensus) on zero revenue, with R&D expen | Aug 12, 2026 |
| GLBE | PRESS-RELEASE | mixed | 6/10 | Global-e Online reported Q2 2026 revenue of $299.0M (+39% YoY) and GAAP diluted EPS of $0.27, missing the $0.31 consensu | Aug 12, 2026 |
| KRNT | PRESS-RELEASE | mixed | 6/10 | Kornit Digital reported Q2 2026 revenue of $55.3M, above the high end of guidance and up 11% YoY from $49.8M, driven by | Aug 12, 2026 |
| LQDA | PRESS-RELEASE | bearish | 6/10 | Liquidia reported Q2 2026 net product sales of $170.4M (+31% QoQ), net income of $74.7M ($0.74 diluted EPS), and adjuste | Aug 12, 2026 |
| SUNE | PRESS-RELEASE | bearish | 6/10 | SUNation Energy reported Q2 2026 revenue of $8.2M, down 37.5% YoY from $13.1M, and a net loss of $3.3M (improved from $9 | Aug 12, 2026 |
| PHVS | PRESS-RELEASE | neutral | 5/10 | Pharvaris reported Q2 2026 results with a loss per share of €0.70, slightly above the consensus EPS estimate of -$0.65 ( | Aug 12, 2026 |
| ANNX | PRESS-RELEASE | bullish | 6/10 | Annexon reported Q2 2026 EPS of -$0.28, slightly wider than the prior year's -$0.34 loss, but the focus is on pipeline c | Aug 12, 2026 |
| STRO | PRESS-RELEASE | mixed | 6/10 | Sutro Biopharma reported Q2 2026 revenue of $9.8M (down 84.6% YoY from $63.7M) and a net loss of $38.5M (-$2.33 EPS), si | Aug 12, 2026 |
| WRD | PRESS-RELEASE | bullish | 6/10 | WeRide reported Q2 2026 revenue of RMB231.7M ($34.2M), up 82.2% YoY and above the $177.6M consensus. Gross margin expand | Aug 12, 2026 |
| FRVO | PRESS-RELEASE | bearish | 6/10 | Fervo Energy reported Q2 2026 earnings with a net loss of $55.9M and an EPS of -$0.38, significantly missing the consens | Aug 12, 2026 |
| MRX | PRESS-RELEASE | bullish | 7/10 | Marex Group reported record Q2 2026 results with revenue of $695.8M (+39% YoY) and Adjusted Profit Before Tax of $165.9M | Aug 12, 2026 |
| HUMA | PRESS-RELEASE | bullish | 7/10 | Humacyte reported Q2 2026 EPS of -$0.09, beating consensus of -$0.10 by 12.9%, with Symvess product revenue of $0.4M (up | Aug 12, 2026 |
| LXEO | PRESS-RELEASE | neutral | 5/10 | Lexeo Therapeutics reported Q2 2026 net loss of $0.30 per share, in line with the $0.28 consensus estimate. The key cata | Aug 12, 2026 |
| OCTV | PRESS-RELEASE | mixed | 6/10 | Octave Intelligence reported Q2 2026 results with adjusted EPS of $0.36, beating the $0.31 consensus by 16.1%, and reven | Aug 12, 2026 |
| TCRX | PRESS-RELEASE | bearish | 6/10 | TScan Therapeutics reported Q2 2026 EPS of -$0.23, a 15% miss vs consensus of -$0.20, and revenue of $1.1M, sharply down | Aug 12, 2026 |
| ABOS | PRESS-RELEASE | bearish | 5/10 | Acumen Pharmaceuticals reported Q2 2026 EPS of -$0.45 (GAAP), missing the Street consensus of -$0.39, while net loss nar | Aug 12, 2026 |
| ITRN | PRESS-RELEASE | bullish | 6/10 | Ituran reported Q2 2026 record revenue of $104.8M (+21% YoY) and EPS of $0.88, exactly in line with the single-analyst c | Aug 12, 2026 |
| TECH | PRESS-RELEASE | neutral | 4/10 | Bio-Techne reported Q4 FY2026 adjusted EPS of $0.52, a 2.1% beat vs $0.52 consensus, on revenue of $321.2M (1% reported | Aug 12, 2026 |
| ALLT | PRESS-RELEASE | bullish | 7/10 | Allot reported Q2 2026 revenue of $27.7M (+15% YoY) and non-GAAP EPS of $0.09, beating consensus estimates of $0.06. The | Aug 12, 2026 |
| EAT | PRESS-RELEASE | bullish | 7/10 | Brinker International (EAT) reported Q4 fiscal 2026 GAAP EPS of $2.99, missing the $3.09 consensus by 3.2%, while total | Aug 12, 2026 |
| TII | PRESS-RELEASE | bullish | 7/10 | Titan Mining reported record Q2 2026 revenue of $25.7M (+57% YoY) and net income of $5.4M ($0.06/share), significantly b | Aug 12, 2026 |
| TE | PRESS-RELEASE | mixed | 6/10 | T1 Energy (TE) reported Q2 2026 results with total net sales of $250.1M, a net loss of $(0.16)/share, and Adjusted EBITD | Aug 12, 2026 |
| LOW | PRESS-RELEASE | neutral | 1/10 | Lowe's Companies, Inc. announced it will host a conference call on August 19 to discuss its Q2 2026 results. | Aug 12, 2026 |
| HITI | PRESS-RELEASE | neutral | 2/10 | High Tide Inc. released voting results from its annual general meeting, with all five director nominees elected by over | Aug 12, 2026 |
| GOTU | PRESS-RELEASE | neutral | 1/10 | Gaotu Techedu Inc. announced it will report its Q2 2026 results on August 27, 2026. | Aug 12, 2026 |
| HY | PRESS-RELEASE | neutral | 3/10 | Hyster announced the deployment of a battery-electric ReachStacker at Inland Terminals Group's Venray-Wanssum terminal, | Aug 12, 2026 |
| TOUR | PRESS-RELEASE | neutral | 1/10 | Tuniu Corporation announced it will report its Q2 2026 results on August 25, 2026. | Aug 12, 2026 |